ATC Group: A07AA09 Vancomycin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A07AA09 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3
Intestinal antiinfectives
4
Antibiotics
5
A07AA09
Vancomycin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
2 g

Active ingredients in A07AA09

Active Ingredient
Description

Vancomycin is a tricyclic glycopeptide antibiotic that inhibits the synthesis of the cell wall in sensitive bacteria by binding with high affinity to the D-alanyl-D-alanine terminus of cell wall precursor units.

Related product monographs

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Canada (CA)

Estonia (EE)

Hong Kong (HK)

Ireland (IE)

Netherlands (NL)

South Africa (ZA)

United Kingdom (UK)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.